Al Farabi Medical Laboratories, which is recognized as one of the best hospitals in the Kingdom of Saudi Arabia, and Dante Labs, which is recognized as a pioneer in the fields of genomics and precision medicine, are pleased to announce a new business partnership that will allow them to provide patients in the Kingdom with a wide range of clinical genomic tests, including Whole Exome Sequencing with interpretation, Whole Genome Sequencing and Non-Invasive Prenatal Testing (NIPT).
Andrea Riposati, the current CEO and co-founder of Dante Labs, has voiced his excitement about the possibility of delivering innovative genetic testing services in conjunction with the Al Farabi Medical Labs in the Kingdom of Saudi Arabia. “We are excited to be of service to Al Farabi Medical Labs as it expands and works toward realizing its vision for the future. Together, our goal is to pave the way for individuals to get medical treatment based on the sequencing of their entire genome.
Al Farabi Medical Laboratories is a well-known medical company with locations in more than 50 different locations around the Kingdom of Saudi Arabia. Dr. Mohamed Marie, the founder of Al Farabi Medical Laboratories and its general manager, said, “We are pleased to put the expertise and technology offered by Dante Labs to use in the Kingdom of Saudi Arabia. Dante Labs will be our partner in analyzing genetic data and producing other genomic products. Our mission continues to be to offer the highest quality treatment for our patients as is humanly feasible.”
Al Farabi Medical Labs
Since the company’s inception, Al Farabi Medical Labs has implemented and continues to pursue the strategy of attracting and localizing the new and current in various diagnostic procedures to work on challenging medical equations in terms of performance quality, turnaround time, and reasonable deal for the service that is being provided. A strict policy has been implemented at Al Farabi Medical Labs to ensure that the company satisfies local and international norms and criteria regarding the quality of the laboratory and the safety of the workplace. As a direct result, the CBAHI and JCI accreditations, both national and worldwide, have been obtained.
Dante Labs is a global company specializing in genetic information that is now working on creating and commercializing a new category of game-changing health and longevity applications based on the sequencing of complete genomes and artificial intelligence. By utilizing its platform, the firm can provide improved patient outcomes, preventative care, enhanced diagnostics, and tailored therapy. The company’s assets include one of the top private genome databases with authorization for research, proprietary software designed to unlock the power of genomic data at scale, and one-of-a-kind technologies that enable an enterprise approach to genomic sequencing.